Ethics & Informed Consent: Randomised Controlled Trial (RCT) (Hong Kong)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Randomised Controlled Trial (RCT) being conducted in Hong Kong, study designs must align with the primary regulatory legislation: Hospital Authority Research Ethics Committee Guidelines. This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Human Research Ethics Committee (HREC). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Randomised Controlled Trial (RCT), the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: High Risk (Interventional)

This interventional trial requires strict protocol adherence, allocation concealment, robust adverse event monitoring, and emergency unblinding guidelines.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: CONSORT statement.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Personal Data (Privacy) Ordinance (PDPO) (Cap. 486).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Human Research Ethics Committee (HREC) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Protecting trial subjects during this Randomised Controlled Trial (RCT) in Hong Kong is rooted in the Belmont Report principles that guide modern medicine. Under active regulations, investigators must explicitly justify if any temporary deception in psychological research is planned for patients. Drafting an exhaustive research study consent form ensures compliance with the informed consent Belmont Report guidelines. Pre-requisites for starting the trial include a formal clinical trial registration and a signed clinical trial agreement contract. If animal models are used, investigators must detail compliance with the 3rs replacement reduction refinement of laboratory models. Ethical oversight committees in Hong Kong audit the study's consent registry periodically to verify compliance with national legal statutes.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions